380 related articles for article (PubMed ID: 1518394)
1. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients.
Agostoni A; Cicardi M
Medicine (Baltimore); 1992 Jul; 71(4):206-15. PubMed ID: 1518394
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune C1 inhibitor deficiency: report of eight patients.
Cicardi M; Bisiani G; Cugno M; Späth P; Agostoni A
Am J Med; 1993 Aug; 95(2):169-75. PubMed ID: 8356982
[TBL] [Abstract][Full Text] [Related]
3. C1-inhibitor deficiency and angioedema.
Carugati A; Pappalardo E; Zingale LC; Cicardi M
Mol Immunol; 2001 Aug; 38(2-3):161-73. PubMed ID: 11532278
[TBL] [Abstract][Full Text] [Related]
4. Clinical problems in the C1-inhibitor deficient patient.
Agostoni A; Cicardi M; Cugno M; Storti E
Behring Inst Mitt; 1993 Dec; (93):306-12. PubMed ID: 8172581
[TBL] [Abstract][Full Text] [Related]
5. [Hereditary angioedema in the German-speaking region].
Göring HD; Bork K; Späth PJ; Bauer R; Ziemer A; Hintner H; Wüthrich B
Hautarzt; 1998 Feb; 49(2):114-22. PubMed ID: 9551333
[TBL] [Abstract][Full Text] [Related]
6. Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency.
Bork K; Witzke G
J Allergy Clin Immunol; 1989 Mar; 83(3):677-82. PubMed ID: 2926086
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic approach of hereditary angioedema].
Chagas Kde N; Arruk VG; Andrade ME; Vasconcelos Dde M; Kirschfink M; Duarte AJ; Grumach AS
Rev Assoc Med Bras (1992); 2004; 50(3):314-9. PubMed ID: 15499486
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
[TBL] [Abstract][Full Text] [Related]
9. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
[TBL] [Abstract][Full Text] [Related]
10. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema.
Bork K; Barnstedt SE
Arch Intern Med; 2001 Mar; 161(5):714-8. PubMed ID: 11231704
[TBL] [Abstract][Full Text] [Related]
11. Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies.
Alsenz J; Lambris JD; Bork K; Loos M
J Clin Invest; 1989 Jun; 83(6):1794-9. PubMed ID: 2723058
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
[TBL] [Abstract][Full Text] [Related]
13. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
[TBL] [Abstract][Full Text] [Related]
14. Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency.
Cugno M; Zanichelli A; Bellatorre AG; Griffini S; Cicardi M
Allergy; 2009 Feb; 64(2):254-7. PubMed ID: 19076541
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience.
Cicardi M; Bergamaschini L; Cugno M; Hack E; Agostoni G; Agostoni A
J Allergy Clin Immunol; 1991 Apr; 87(4):768-73. PubMed ID: 2013670
[TBL] [Abstract][Full Text] [Related]
16. Pathogenetic and clinical aspects of C1 inhibitor deficiency.
Cicardi M; Bergamaschini L; Cugno M; Beretta A; Zingale LC; Colombo M; Agostoni A
Immunobiology; 1998 Aug; 199(2):366-76. PubMed ID: 9777420
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune C1 inhibitor deficiency and angioedema.
Valsecchi R; Reseghetti A; Pansera B; Di Landro A
Dermatology; 1997; 195(2):169-72. PubMed ID: 9310729
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study.
Martinez-Saguer I; Rusicke E; Aygören-Pürsün E; von Hentig N; Klingebiel T; Kreuz W
Transfusion; 2010 Feb; 50(2):354-60. PubMed ID: 19788511
[TBL] [Abstract][Full Text] [Related]
19. Short-term prophylaxis in patients with angioedema due to C1-inhibitor deficiency undergoing dental procedures: An observational study.
Zanichelli A; Ghezzi M; Santicchia I; Vacchini R; Cicardi M; Sparaco A; Donati G; Ranìa V; Busa A
PLoS One; 2020; 15(3):e0230128. PubMed ID: 32163480
[TBL] [Abstract][Full Text] [Related]
20. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
